{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:07Z","timestamp":1794893587051,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.humpath.2010.07.023","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T09:15:29Z","timestamp":1296724529000},"page":"679-687","source":"Crossref","is-referenced-by-count":28,"title":["Natural killer cell subsets and natural killer\u2013like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features"],"prefix":"10.1016","volume":"42","author":[{"given":"Sarah E.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond E.","family":"Felgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2010.07.023_bb0005","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.07.023_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2007.06841.x","article-title":"Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo","volume":"140","author":"Reddy","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0020","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.07.023_bb0025","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-07-0778","article-title":"A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone","volume":"13","author":"Taskinen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2010.07.023_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2141.2003.04679.x","article-title":"Role of the microenvironment in chronic lymphocytic leukemia","volume":"123","author":"Caligaris-Cappio","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2141.2008.07070.x","article-title":"Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia","volume":"141","author":"Palmer","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/annonc\/mdm110","article-title":"Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma","volume":"18","author":"Plonquet","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0045","first-page":"2123","article-title":"Cytotoxic lymphocytes in the peripheral blood of patients with B cell lymphomas","volume":"9","author":"Kuriyama","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2010.07.023_bb0050","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/1097-0142(19821201)50:11<2333::AID-CNCR2820501119>3.0.CO;2-W","article-title":"Low natural killer cell activity in patients with malignant lymphoma","volume":"50","author":"Tursz","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.07.023_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.07.023_bb0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.2007.06835.x","article-title":"Progress in understanding and managing natural killer-cell malignancies","volume":"139","author":"Oshimi","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0047-6374(00)00199-8","article-title":"Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector\/senescent T cells","volume":"121","author":"Tarazona","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.humpath.2010.07.023_bb0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/10428190903552120","article-title":"Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy","volume":"51","author":"Olteanu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2010.07.023_bb0075","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1158\/1078-0432.CCR-1087-3","article-title":"Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-Hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response","volume":"10","author":"Gluck","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2010.07.023_bb0080","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-07-4405","article-title":"Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells","volume":"14","author":"Wu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2010.07.023_bb0085","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.humpath.2010.07.023_bb0090","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2010.07.023_bb0095","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2010.07.023_bb0100","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.07.023_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.07.023_bb0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2141.2007.06974.x","article-title":"Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA\/CD16","volume":"140","author":"de Romeuf","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0115","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.4049\/jimmunol.131.4.1789","article-title":"Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens","volume":"131","author":"Lanier","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0120","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.143.10.3183","article-title":"Comparative studies of human FcRIII-positive and negative natural killer cells","volume":"143","author":"Nagler","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0125","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1084\/jem.161.6.1464","article-title":"Model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer\u2013sensitive tumor cell, K562","volume":"161","author":"Phillips","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.humpath.2010.07.023_bb0130","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/sj.leu.2401146","article-title":"CD57+\/CD28\u2212 T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendendy to apoptosis","volume":"12","author":"Van den Hove","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2010.07.023_bb0135","first-page":"172","article-title":"Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type","volume":"113","author":"Harris","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.07.023_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10428199309148509","article-title":"Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas","volume":"9","author":"Diaz","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2010.07.023_bb0150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.2007.06593.x","article-title":"The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma","volume":"137","author":"Hasselblom","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00184787","article-title":"Distribution of lymphocyte subsets and natural killer cells in the human body","volume":"70","author":"Westermann","year":"1992","journal-title":"Clin Investig"},{"key":"10.1016\/j.humpath.2010.07.023_bb0160","first-page":"166","article-title":"Heterogeneity of human natural killer cells in the spleen","volume":"69","author":"Witte","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.humpath.2010.07.023_bb0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.gastro.2007.05.017","article-title":"Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells","volume":"133","author":"Chinen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2010.07.023_bb0170","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1002\/eji.200838849","article-title":"Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues","volume":"38","author":"M\u00fcnz","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.humpath.2010.07.023_bb0175","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ajh.21468","article-title":"Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo","volume":"84","author":"Zhang","year":"2009","journal-title":"Am J Hematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T20:11:39Z","timestamp":1712175099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817710003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0046817710003588"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2010.07.023","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}